Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers - sprookjes - yvandenbroek - TriplyDB

Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers

Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers

http://www.wikidata.org/entity/Q28742090

about

Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population Predictive biomarkers in precision medicine and drug development against lung cancer HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approaches Advances of molecular subtype and targeted therapy of lung cancer Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement.ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.Testing for ROS1 in non-small cell lung cancer: a review with recommendations Significance of persistent inflammation in respiratory disorders induced by nanoparticles Characteristics of lung cancers harboring NRAS mutations Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts Clinicopathological and demographical characteristics of non-small cell lung cancer patients with ALK rearrangements: a systematic review and meta-analysis.Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer.Time-varying pattern of postoperative recurrence risk of early-stage (T1a-T2bN0M0) non-small cell lung cancer (NSCLC): results of a single-center study of 994 Chinese patients.Targeted therapies in non-small cell lung cancer: emerging oncogene targets following the success of epidermal growth factor receptor.Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.Molecular pathways: ROS1 fusion proteins in cancer.Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup Epidermal growth factor receptor gene mutations in patients with lung adenocarcinoma differ by frequency and type between Uighur and Han ethnic groups in Xinjiang Autonomous Region.Lung cancer molecular epidemiology in China: recent trends The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience.Lung cancer mutations and use of targeted agents in Hispanics Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma Lung cancer in never-smoker Asian females is driven by oncogenic mutations, most often involving EGFR Clinicopathologic characteristics of patients with ROS1 fusion gene in non-small cell lung cancer: a meta-analysis.Compound Library Screening Identified Cardiac Glycoside Digitoxin as an Effective Growth Inhibitor of Gefitinib-Resistant Non-Small Cell Lung Cancer via Downregulation of α-Tubulin and Inhibition of Microtubule Formation.New approaches to targeted therapy in lung cancer.Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer.Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population.Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma Translating genomic information into clinical medicine: lung cancer as a paradigm.Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology The introduction of systematic genomic testing for patients with non-small-cell lung cancer Cancer genes in lung cancer: racial disparities: are there any?Thymic neoplasm: a rare disease with a complex clinical presentation

P2860

Q26786594-10D16BE3-4455-405A-8C4D-29E8AE662F97 Q26824536-F0CA5766-56A7-4E07-835F-14C8034007A9 Q26866534-FAAFC2B9-A237-408C-90E5-58D87224FC82 Q27030813-EB2C95C4-CAC4-4E96-8B4F-970935770CA1 Q27311389-E31EB4A0-7451-407B-9C01-8BDE0746CC5B Q27852699-F91CF9FA-4F52-4969-9E12-C80CE18E3281 Q28070062-B0236472-B1BA-417D-AD02-FC8AD0CBC2AC Q28390890-7ECD3DCF-43BC-4D75-8462-23AD9F62B4BA Q28706226-77DCA5DC-3656-4F10-BC58-494A54B5A5DB Q28943345-8298B6C8-3E32-4B9F-A6CE-246486F8DDE3 Q31140151-4888A8B6-C428-42C0-A06E-AA2785AF4F12 Q31167585-016AB040-A6E9-4600-B331-E55C6FF6E8F9 Q34150095-A4953FFE-A557-4ADC-AD8B-D9BE36997F9D Q34155998-71B16056-117D-4688-B3D8-12DA04339AE4 Q34158153-CAC0E065-EF91-4E66-B4A5-28F0361FA896 Q34295696-36C226F7-2EEF-4AC9-A378-34BF09ABC917 Q34347504-741FFB75-2226-4F13-AAC7-9F4FAA62C036 Q34522899-97CE4BCE-33BB-4614-A138-34777F90E80E Q34712122-6D597452-9AD1-48AE-945F-1B1F92A624B2 Q35095308-792AD97F-4322-4760-B775-7FC559323EFF Q35164907-FA82C2E6-07D0-4558-A2C2-9FA4851A5EB5 Q35200702-C97DE629-3BBB-49F8-B765-EECA483F5C3B Q35532823-D0A5D0FB-F04D-4975-B3CF-79860DB80C70 Q35541778-E5373944-909E-4AE2-82AE-A7DE79229DC1 Q35636924-26A44C1A-9A33-4B4A-91C4-FCAFD14B15DB Q35671830-F72679ED-1939-4086-A4DA-69725731B582 Q35741716-2C92027E-7A35-44F0-AFAF-F464CE313871 Q35790161-A9C736D6-431B-41C2-9F5E-1C431B21187C Q35964756-00B1B5FF-9FF1-48E2-90DE-4A6F1E0C61C2 Q35984001-B2712FDC-FA07-43AD-B9C0-28B6A5C91ECF Q36044531-7CA8889C-D2FF-4827-9A1F-A5E7253DBC24 Q36104115-1542E249-2BFA-4C45-81BB-077F917334D9 Q36195557-24EA7519-4F38-45FD-81D4-3C9E87C12EC4 Q36203525-8088C0AD-24DA-4EA6-AF2D-8A836A3574C7 Q36287463-660264F8-A773-47AB-A6EC-C77CA696DBEA Q36354845-9360F941-05EC-4006-B88F-CEB239AB31DA Q36405628-5BF5ADF4-AEC1-4747-A99A-4B89CB34DAFF Q36406223-631F28E5-6802-4876-9605-18CD33AB57D5 Q36481954-1E8D1033-630A-46B8-831B-00B943509839 Q36753888-394B9CC3-5351-4DB2-ADDC-69511BEC2753

P2860

Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers

http://www.wikidata.org/entity/Q28742090

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Spectrum of oncogenic driver m ...... from East Asian never smokers

@ast

Spectrum of oncogenic driver m ...... from East Asian never smokers

@en

Spectrum of oncogenic driver m ...... from East Asian never smokers

@nl

type

label

Spectrum of oncogenic driver m ...... from East Asian never smokers

@ast

Spectrum of oncogenic driver m ...... from East Asian never smokers

@en

Spectrum of oncogenic driver m ...... from East Asian never smokers

@nl

prefLabel

Spectrum of oncogenic driver m ...... from East Asian never smokers

@ast

Spectrum of oncogenic driver m ...... from East Asian never smokers

@en

Spectrum of oncogenic driver m ...... from East Asian never smokers

@nl

P1433

Q28742090-0AA1F4A6-BBA9-4C4D-83B8-2177E85B97D0

P1476

Q28742090-D5298EA1-43B5-4E27-A380-9B8F90BEDD32

P2093

Q28742090-1A29FA26-DDDA-4146-95D8-C5BE6D5A9F0B

Q28742090-4C167AB1-D142-4359-B3C4-B2875D1D7FF8

Q28742090-4D12D34E-ABBF-47AE-8562-D8459D6E0F39

Q28742090-54DFB6D3-8D9A-4D8D-BB43-BE4891A166C7

Q28742090-5E8B9FE0-9F67-46EB-BEB0-8C4E892204D5

Q28742090-884C7F1D-F806-4EDD-BC0A-3E8DC9BDA4E0

Q28742090-9DE975A6-B5C2-4078-9DD2-E431D33F869F

Q28742090-CACC65EC-4859-486D-AFFE-02AEE1D64CF1

Q28742090-E4A49BC1-0FCF-405F-89D2-C4337F224275

Q28742090-F5EA2960-B192-4657-82B1-324DC31319BE

P2860

Q28742090-1FD18166-546B-45CD-98B5-393069F08200

Q28742090-226C0424-56FC-4DA0-8FAE-B6240CCA6696

Q28742090-28D7524F-B877-4BD1-85F2-B49304939013

Q28742090-44AA48D2-6331-4C8C-9A76-6705AFCECB42

Q28742090-586BF40A-0B70-422B-B597-8427E629F3AA

Q28742090-5C5C1046-D79A-47B2-AA9D-C274465AAE60

Q28742090-7763BD63-FD59-4727-ADF0-FE0376FDE255

Q28742090-7DAA8F00-FB1D-4267-8706-EDB72CA2F147

Q28742090-8E6A406A-AF43-4A98-82BF-6F22AA06D9E6

Q28742090-9D94FB5D-C223-4738-9077-799852DD6C6F

P304

Q28742090-4B427049-3135-4CCC-BCFE-B3E62617811B

P31

Q28742090-EA226C4F-29E7-450C-99DE-2C5367576735

P3181

Q28742090-E0FA9AB1-14C7-4883-88DA-4CE731CC47F4

P356

Q28742090-7549D367-7954-4F47-B705-2B01146940B9

P407

Q28742090-D2B9015D-C38A-40B6-AE16-A1003E8E4801

P433

Q28742090-0B2977EA-BF79-4A73-B3A8-26493DB684D8

P478

Q28742090-D2BED6B6-EE59-4FC0-84E1-AE17033C242D

P50

Q28742090-68AB4A6C-73B0-47D0-B9A3-58FAC7EC4D97

P577

Q28742090-37F724E4-3F64-428B-929E-8956D6113BFB

P5875

Q28742090-C8B5AA22-4D89-4EB8-A02C-4569AE05852D

P698

Q28742090-59A796CA-980D-4EFD-B2AF-1A5F95756F19

P921

Q28742090-46FEA3BB-9C15-4A8B-9893-844A3E6A1BD4

P932

Q28742090-4612F116-1479-42EF-8C58-974E0276E714

P3181

P356

JOURNAL.PONE.0028204

P1433

P1476

Spectrum of oncogenic driver m ...... from East Asian never smokers

@en

P2093

A John Iafrate

http://www.w3.org/2001/XMLSchema#string

Bin Gao

http://www.w3.org/2001/XMLSchema#string

Chenguang Li

http://www.w3.org/2001/XMLSchema#string

Fei Li

http://www.w3.org/2001/XMLSchema#string

Haiquan Chen

http://www.w3.org/2001/XMLSchema#string

Hongbin Ji

http://www.w3.org/2001/XMLSchema#string

Rong Fang

http://www.w3.org/2001/XMLSchema#string

Xiangkun Han

http://www.w3.org/2001/XMLSchema#string

Xin-Yuan Liu

http://www.w3.org/2001/XMLSchema#string

Yihua Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies

Somatic mutations affect key pathways in lung adenocarcinoma

Characterizing the cancer genome in lung adenocarcinoma.

Cancer statistics, 2010

Global cancer statistics, 2002

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

Lung cancer in never smokers: a review

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.

Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.

P304

e28204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4043292

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0028204

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51852672

http://www.w3.org/2001/XMLSchema#string

P698

22140546

http://www.w3.org/2001/XMLSchema#string

P921

P932

3227646

http://www.w3.org/2001/XMLSchema#string